[
  {
    "ts": null,
    "headline": "Teva: Branded Momentum Clashes With Generic Declines And IRA Headwinds",
    "summary": "Teva's business is encountering headwinds, including declining U.S. generics revenue. Read what this biotech plans to do in 2025.",
    "url": "https://finnhub.io/api/news?id=ed9c1dc76f42cec6cd7112ebcdea969d1cf3ac0f886aef5a7ed3ef0156cd872f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741264038,
      "headline": "Teva: Branded Momentum Clashes With Generic Declines And IRA Headwinds",
      "id": 133067284,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445064010/image_1445064010.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Teva's business is encountering headwinds, including declining U.S. generics revenue. Read what this biotech plans to do in 2025.",
      "url": "https://finnhub.io/api/news?id=ed9c1dc76f42cec6cd7112ebcdea969d1cf3ac0f886aef5a7ed3ef0156cd872f"
    }
  }
]